Globus Medical receives FDA 510k clearance for ExcelsiusFlex, ACTIFY

Globus Medical announced it recently received 510(k) clearance by the U.S. Food and Drug Administration, FDA, for ExcelsiusFlex with Total Knee Arthroplasty, TKA, application. This new robotic navigation platform joins the already best-in-class Excelsius ecosystem, designed to offer surgeons control, resection accuracy, and procedural flexibility in Total Knee Arthroplasty. Additionally, ACTIFY 3D Total Knee System, the latest in implant technology that will pair with ExcelsiusFlex, has also received 510(k) clearance. “With the addition of ExcelsiusFlex and ACTIFY 3D, we look forward to introducing next generation robotic technology along with the next generation of implant technology to the orthopedic market,” commented Dan Scavilla, president and CEO of Globus Medical. “The precision, efficiency, and flexibility these systems offer will help to provide surgeons a best-in-class solution for treating patients.”